nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—CYP2E1—liver cancer	0.27	0.646	CbGaD
Chlorpromazine—ALB—liver cancer	0.149	0.355	CbGaD
Chlorpromazine—HTR2B—Sorafenib—liver cancer	0.0877	0.288	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—liver cancer	0.0643	0.211	CbGbCtD
Chlorpromazine—HTR2C—Sorafenib—liver cancer	0.0571	0.188	CbGbCtD
Chlorpromazine—ABCB11—bile canaliculus—liver cancer	0.0479	0.508	CbGeAlD
Chlorpromazine—CYP1A2—Sorafenib—liver cancer	0.0208	0.0683	CbGbCtD
Chlorpromazine—ABCB1—Sorafenib—liver cancer	0.0182	0.0597	CbGbCtD
Chlorpromazine—CYP2D6—Sorafenib—liver cancer	0.0171	0.0563	CbGbCtD
Chlorpromazine—ABCB11—bile duct—liver cancer	0.015	0.159	CbGeAlD
Chlorpromazine—ABCB11—bile—liver cancer	0.0115	0.122	CbGeAlD
Chlorpromazine—ABCB1—Doxorubicin—liver cancer	0.011	0.0363	CbGbCtD
Chlorpromazine—CYP3A4—Sorafenib—liver cancer	0.0109	0.0358	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—liver cancer	0.0104	0.0342	CbGbCtD
Chlorpromazine—BCHE—diaphragm—liver cancer	0.00664	0.0704	CbGeAlD
Chlorpromazine—CYP3A4—Doxorubicin—liver cancer	0.0066	0.0217	CbGbCtD
Chlorpromazine—ALB—gall bladder—liver cancer	0.00173	0.0184	CbGeAlD
Chlorpromazine—CALM2—gall bladder—liver cancer	0.00147	0.0156	CbGeAlD
Chlorpromazine—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0012	0.0423	CcSEcCtD
Chlorpromazine—SMPD1—liver—liver cancer	0.00118	0.0125	CbGeAlD
Chlorpromazine—Endocrine disorder—Sorafenib—liver cancer	0.00105	0.0371	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Epirubicin—liver cancer	0.000963	0.0341	CcSEcCtD
Chlorpromazine—ABCB11—liver—liver cancer	0.000937	0.00993	CbGeAlD
Chlorpromazine—CALM2—embryo—liver cancer	0.000932	0.00988	CbGeAlD
Chlorpromazine—CALM1—embryo—liver cancer	0.000927	0.00983	CbGeAlD
Chlorpromazine—Pigmentation disorder—Doxorubicin—liver cancer	0.000891	0.0315	CcSEcCtD
Chlorpromazine—Gynaecomastia—Sorafenib—liver cancer	0.000778	0.0275	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Sorafenib—liver cancer	0.000669	0.0237	CcSEcCtD
Chlorpromazine—HTR2A—embryo—liver cancer	0.000565	0.00599	CbGeAlD
Chlorpromazine—CALM3—liver—liver cancer	0.000549	0.00582	CbGeAlD
Chlorpromazine—Dysphagia—Sorafenib—liver cancer	0.000546	0.0193	CcSEcCtD
Chlorpromazine—SLC22A1—liver—liver cancer	0.000531	0.00563	CbGeAlD
Chlorpromazine—ALB—liver—liver cancer	0.000508	0.00539	CbGeAlD
Chlorpromazine—Erectile dysfunction—Sorafenib—liver cancer	0.000503	0.0178	CcSEcCtD
Chlorpromazine—Jaundice—Sorafenib—liver cancer	0.000474	0.0168	CcSEcCtD
Chlorpromazine—CALM2—liver—liver cancer	0.000431	0.00457	CbGeAlD
Chlorpromazine—CALM1—liver—liver cancer	0.000429	0.00455	CbGeAlD
Chlorpromazine—HTR7—liver—liver cancer	0.000419	0.00444	CbGeAlD
Chlorpromazine—ADRA1A—liver—liver cancer	0.000404	0.00428	CbGeAlD
Chlorpromazine—Glycosuria—Epirubicin—liver cancer	0.000397	0.014	CcSEcCtD
Chlorpromazine—Blood disorder—Epirubicin—liver cancer	0.000385	0.0136	CcSEcCtD
Chlorpromazine—ABCB1—embryo—liver cancer	0.00037	0.00392	CbGeAlD
Chlorpromazine—Glycosuria—Doxorubicin—liver cancer	0.000367	0.013	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Epirubicin—liver cancer	0.000366	0.0129	CcSEcCtD
Chlorpromazine—Amenorrhoea—Epirubicin—liver cancer	0.000366	0.0129	CcSEcCtD
Chlorpromazine—Muscle spasms—Sorafenib—liver cancer	0.000366	0.0129	CcSEcCtD
Chlorpromazine—BCHE—liver—liver cancer	0.000359	0.00381	CbGeAlD
Chlorpromazine—Blood disorder—Doxorubicin—liver cancer	0.000356	0.0126	CcSEcCtD
Chlorpromazine—Angioedema—Sorafenib—liver cancer	0.000347	0.0123	CcSEcCtD
Chlorpromazine—Dyskinesia—Epirubicin—liver cancer	0.000342	0.0121	CcSEcCtD
Chlorpromazine—Syncope—Sorafenib—liver cancer	0.000341	0.0121	CcSEcCtD
Chlorpromazine—Leukopenia—Sorafenib—liver cancer	0.00034	0.012	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—liver cancer	0.000338	0.012	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—liver cancer	0.000338	0.012	CcSEcCtD
Chlorpromazine—CYP1A2—liver—liver cancer	0.000334	0.00354	CbGeAlD
Chlorpromazine—Loss of consciousness—Sorafenib—liver cancer	0.000334	0.0118	CcSEcCtD
Chlorpromazine—Cough—Sorafenib—liver cancer	0.000332	0.0117	CcSEcCtD
Chlorpromazine—Gait disturbance—Epirubicin—liver cancer	0.000329	0.0117	CcSEcCtD
Chlorpromazine—Dermatitis contact—Epirubicin—liver cancer	0.000318	0.0112	CcSEcCtD
Chlorpromazine—Dry mouth—Sorafenib—liver cancer	0.000317	0.0112	CcSEcCtD
Chlorpromazine—Dyskinesia—Doxorubicin—liver cancer	0.000316	0.0112	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Sorafenib—liver cancer	0.00031	0.011	CcSEcCtD
Chlorpromazine—Infection—Sorafenib—liver cancer	0.000308	0.0109	CcSEcCtD
Chlorpromazine—Shock—Sorafenib—liver cancer	0.000305	0.0108	CcSEcCtD
Chlorpromazine—Gait disturbance—Doxorubicin—liver cancer	0.000305	0.0108	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Epirubicin—liver cancer	0.000302	0.0107	CcSEcCtD
Chlorpromazine—CYP2E1—liver—liver cancer	0.000301	0.00319	CbGeAlD
Chlorpromazine—Dermatitis contact—Doxorubicin—liver cancer	0.000294	0.0104	CcSEcCtD
Chlorpromazine—Clomipramine—GSTP1—liver cancer	0.000282	0.159	CrCbGaD
Chlorpromazine—Aplastic anaemia—Doxorubicin—liver cancer	0.000279	0.00988	CcSEcCtD
Chlorpromazine—Dyspnoea—Sorafenib—liver cancer	0.000277	0.00979	CcSEcCtD
Chlorpromazine—Photosensitivity—Epirubicin—liver cancer	0.000266	0.0094	CcSEcCtD
Chlorpromazine—Constipation—Sorafenib—liver cancer	0.000265	0.00939	CcSEcCtD
Chlorpromazine—HTR2A—liver—liver cancer	0.000261	0.00277	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000247	0.00875	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—liver cancer	0.000246	0.0087	CcSEcCtD
Chlorpromazine—Body temperature increased—Sorafenib—liver cancer	0.000245	0.00868	CcSEcCtD
Chlorpromazine—CYP3A4—liver—liver cancer	0.000242	0.00256	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000241	0.00853	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—liver cancer	0.000239	0.00846	CcSEcCtD
Chlorpromazine—CYP2D6—liver—liver cancer	0.000238	0.00252	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000229	0.0081	CcSEcCtD
Chlorpromazine—Hypersensitivity—Sorafenib—liver cancer	0.000229	0.00809	CcSEcCtD
Chlorpromazine—Carbinoxamine—CYP2E1—liver cancer	0.000226	0.128	CrCbGaD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000223	0.00789	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—liver cancer	0.000222	0.00785	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—liver cancer	0.000221	0.00783	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Epirubicin—liver cancer	0.000213	0.00754	CcSEcCtD
Chlorpromazine—Cardiac arrest—Doxorubicin—liver cancer	0.000205	0.00726	CcSEcCtD
Chlorpromazine—Dizziness—Sorafenib—liver cancer	0.000205	0.00726	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—liver cancer	0.000202	0.00714	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—liver cancer	0.000202	0.00714	CcSEcCtD
Chlorpromazine—Dysphagia—Epirubicin—liver cancer	0.000202	0.00714	CcSEcCtD
Chlorpromazine—Eosinophilia—Epirubicin—liver cancer	0.0002	0.00707	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000197	0.00698	CcSEcCtD
Chlorpromazine—Pancytopenia—Epirubicin—liver cancer	0.000192	0.00678	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—liver cancer	0.000187	0.0066	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—liver cancer	0.000187	0.0066	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—liver cancer	0.000187	0.0066	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—liver cancer	0.000185	0.00654	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Epirubicin—liver cancer	0.000184	0.00651	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Epirubicin—liver cancer	0.000182	0.00644	CcSEcCtD
Chlorpromazine—Drowsiness—Epirubicin—liver cancer	0.00018	0.00636	CcSEcCtD
Chlorpromazine—Pancytopenia—Doxorubicin—liver cancer	0.000177	0.00627	CcSEcCtD
Chlorpromazine—Jaundice—Epirubicin—liver cancer	0.000175	0.0062	CcSEcCtD
Chlorpromazine—ABCB1—liver—liver cancer	0.000171	0.00181	CbGeAlD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00017	0.00603	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Doxorubicin—liver cancer	0.000168	0.00596	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—liver cancer	0.000168	0.00594	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—liver cancer	0.000166	0.00589	CcSEcCtD
Chlorpromazine—Jaundice—Doxorubicin—liver cancer	0.000162	0.00574	CcSEcCtD
Chlorpromazine—Oedema peripheral—Epirubicin—liver cancer	0.000159	0.00563	CcSEcCtD
Chlorpromazine—Fluphenazine—CYP2E1—liver cancer	0.000158	0.0894	CrCbGaD
Chlorpromazine—Visual impairment—Epirubicin—liver cancer	0.000156	0.0055	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—liver cancer	0.000155	0.00549	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—liver cancer	0.000147	0.00521	CcSEcCtD
Chlorpromazine—Visual impairment—Doxorubicin—liver cancer	0.000144	0.00509	CcSEcCtD
Chlorpromazine—Nervousness—Epirubicin—liver cancer	0.000136	0.00483	CcSEcCtD
Chlorpromazine—Thioridazine—CYP2E1—liver cancer	0.000136	0.077	CrCbGaD
Chlorpromazine—Muscle spasms—Epirubicin—liver cancer	0.000135	0.00478	CcSEcCtD
Chlorpromazine—Flurazepam—CYP2E1—liver cancer	0.000134	0.076	CrCbGaD
Chlorpromazine—Methotrimeprazine—CYP2E1—liver cancer	0.00013	0.0735	CrCbGaD
Chlorpromazine—Nervousness—Doxorubicin—liver cancer	0.000126	0.00447	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—liver cancer	0.000126	0.00446	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—liver cancer	0.000126	0.00445	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—liver cancer	0.000125	0.00442	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—liver cancer	0.000123	0.00437	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—liver cancer	0.000123	0.00434	CcSEcCtD
Chlorpromazine—Convulsion—Epirubicin—liver cancer	0.000122	0.00431	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—liver cancer	0.000117	0.00414	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—liver cancer	0.000117	0.00413	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—liver cancer	0.000116	0.00412	CcSEcCtD
Chlorpromazine—Desipramine—CYP2E1—liver cancer	0.000116	0.0658	CrCbGaD
Chlorpromazine—Anaphylactic shock—Epirubicin—liver cancer	0.000115	0.00406	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—liver cancer	0.000114	0.00404	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—liver cancer	0.000114	0.00403	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—liver cancer	0.000113	0.00401	CcSEcCtD
Chlorpromazine—Shock—Epirubicin—liver cancer	0.000113	0.00399	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—liver cancer	0.000113	0.00399	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—liver cancer	0.000112	0.00396	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—liver cancer	0.000108	0.00383	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—liver cancer	0.000107	0.00379	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—liver cancer	0.000106	0.00376	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—liver cancer	0.000105	0.00373	CcSEcCtD
Chlorpromazine—Acepromazine—ALB—liver cancer	0.000104	0.0591	CrCbGaD
Chlorpromazine—Shock—Doxorubicin—liver cancer	0.000104	0.00369	CcSEcCtD
Chlorpromazine—Insomnia—Epirubicin—liver cancer	0.000104	0.00367	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—liver cancer	0.000104	0.00366	CcSEcCtD
Chlorpromazine—Dyspnoea—Epirubicin—liver cancer	0.000102	0.00362	CcSEcCtD
Chlorpromazine—Thioproperazine—ALB—liver cancer	0.000102	0.0577	CrCbGaD
Chlorpromazine—Somnolence—Epirubicin—liver cancer	0.000102	0.00361	CcSEcCtD
Chlorpromazine—Thiothixene—ALB—liver cancer	0.0001	0.0568	CrCbGaD
Chlorpromazine—Pipotiazine—ALB—liver cancer	0.0001	0.0568	CrCbGaD
Chlorpromazine—Hypotension—Doxorubicin—liver cancer	9.91e-05	0.00351	CcSEcCtD
Chlorpromazine—Imipramine—CYP2E1—liver cancer	9.86e-05	0.0558	CrCbGaD
Chlorpromazine—Constipation—Epirubicin—liver cancer	9.81e-05	0.00347	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—liver cancer	9.6e-05	0.0034	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—liver cancer	9.46e-05	0.00335	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—liver cancer	9.43e-05	0.00334	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—liver cancer	9.07e-05	0.00321	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—liver cancer	9.07e-05	0.00321	CcSEcCtD
Chlorpromazine—Hypersensitivity—Epirubicin—liver cancer	8.45e-05	0.00299	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—liver cancer	8.39e-05	0.00297	CcSEcCtD
Chlorpromazine—Clomipramine—ALB—liver cancer	7.94e-05	0.0449	CrCbGaD
Chlorpromazine—Hypersensitivity—Doxorubicin—liver cancer	7.82e-05	0.00277	CcSEcCtD
Chlorpromazine—Dizziness—Epirubicin—liver cancer	7.58e-05	0.00268	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—liver cancer	7.02e-05	0.00248	CcSEcCtD
Chlorpromazine—DRD1—Signaling Pathways—TP53—liver cancer	2.77e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—liver cancer	2.77e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—HRAS—liver cancer	2.76e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MYC—liver cancer	2.76e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP9—liver cancer	2.76e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	2.75e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	2.75e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KRAS—liver cancer	2.74e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—STAT3—liver cancer	2.74e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CG—liver cancer	2.73e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—liver cancer	2.73e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—PIK3CA—liver cancer	2.73e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—PIK3CA—liver cancer	2.73e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—liver cancer	2.72e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CDKN1B—liver cancer	2.72e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—liver cancer	2.72e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—AKT1—liver cancer	2.72e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—AKT1—liver cancer	2.71e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—liver cancer	2.71e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—liver cancer	2.7e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—STAT3—liver cancer	2.69e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP1A1—liver cancer	2.69e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—STAT3—liver cancer	2.69e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—IL6—liver cancer	2.69e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	2.68e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—STAT3—liver cancer	2.68e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KRAS—liver cancer	2.68e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—liver cancer	2.68e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—liver cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—liver cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—liver cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—STAT3—liver cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	2.66e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KRAS—liver cancer	2.66e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CASP3—liver cancer	2.66e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL2—liver cancer	2.66e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KRAS—liver cancer	2.65e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KRAS—liver cancer	2.65e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—liver cancer	2.65e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—STAT3—liver cancer	2.65e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—IL6—liver cancer	2.64e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PIK3CA—liver cancer	2.64e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PIK3CA—liver cancer	2.64e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—STAT3—liver cancer	2.64e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARG—liver cancer	2.64e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CDKN1B—liver cancer	2.63e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CDKN1B—liver cancer	2.63e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CB—liver cancer	2.62e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—liver cancer	2.61e-06	1.71e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—liver cancer	2.6e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—liver cancer	2.59e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—JUN—liver cancer	2.59e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CASP3—liver cancer	2.58e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CASP3—liver cancer	2.58e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL2—liver cancer	2.57e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL2—liver cancer	2.57e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CTNNB1—liver cancer	2.57e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—IL6—liver cancer	2.56e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—IL6—liver cancer	2.56e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KRAS—liver cancer	2.55e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MYC—liver cancer	2.54e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TGFB1—liver cancer	2.54e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—IL6—liver cancer	2.53e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—liver cancer	2.52e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PIK3CA—liver cancer	2.52e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PIK3CA—liver cancer	2.52e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—liver cancer	2.52e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—MTHFR—liver cancer	2.51e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CDKN1A—liver cancer	2.51e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—liver cancer	2.51e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—liver cancer	2.51e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MYC—liver cancer	2.5e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—JUN—liver cancer	2.5e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—JUN—liver cancer	2.5e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—IL6—liver cancer	2.5e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MYC—liver cancer	2.5e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TGFB1—liver cancer	2.5e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TGFB1—liver cancer	2.49e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MYC—liver cancer	2.49e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TGFB1—liver cancer	2.48e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MYC—liver cancer	2.48e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CTNNB1—liver cancer	2.48e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CTNNB1—liver cancer	2.48e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—liver cancer	2.48e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TGFB1—liver cancer	2.48e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	2.48e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CB—liver cancer	2.47e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARA—liver cancer	2.46e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	2.46e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MYC—liver cancer	2.46e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TGFB1—liver cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MYC—liver cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—STAT3—liver cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MAPK8—liver cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—liver cancer	2.44e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—liver cancer	2.44e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—liver cancer	2.44e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PIK3CA—liver cancer	2.44e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PIK3CA—liver cancer	2.44e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—liver cancer	2.43e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—liver cancer	2.43e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CDKN1A—liver cancer	2.42e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CDKN1A—liver cancer	2.42e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL6—liver cancer	2.42e-06	1.58e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CD—liver cancer	2.4e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—liver cancer	2.38e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—ALB—liver cancer	2.37e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—liver cancer	2.37e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MAPK8—liver cancer	2.37e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MAPK8—liver cancer	2.37e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—liver cancer	2.36e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—liver cancer	2.36e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KRAS—liver cancer	2.35e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	2.34e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL6—liver cancer	2.34e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL6—liver cancer	2.34e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—liver cancer	2.34e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—liver cancer	2.33e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KRAS—liver cancer	2.31e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PIK3CA—liver cancer	2.31e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KRAS—liver cancer	2.31e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—liver cancer	2.31e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KRAS—liver cancer	2.3e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KRAS—liver cancer	2.29e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MYC—liver cancer	2.28e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—liver cancer	2.28e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	2.27e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KRAS—liver cancer	2.27e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—liver cancer	2.27e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KRAS—liver cancer	2.27e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—liver cancer	2.26e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—liver cancer	2.26e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—liver cancer	2.25e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—liver cancer	2.25e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—STAT3—liver cancer	2.24e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—IL6—liver cancer	2.23e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—liver cancer	2.23e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—liver cancer	2.23e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—liver cancer	2.19e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—liver cancer	2.19e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—IL6—liver cancer	2.18e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—liver cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—IL6—liver cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—STAT3—liver cancer	2.16e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—STAT3—liver cancer	2.16e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PIK3CA—liver cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—IL6—liver cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—IL6—liver cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—liver cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—liver cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PIK3CA—liver cancer	2.13e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PIK3CA—liver cancer	2.12e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PIK3CA—liver cancer	2.12e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PIK3CA—liver cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KRAS—liver cancer	2.1e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.09e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—liver cancer	2.09e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.09e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MYC—liver cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IL6—liver cancer	2.07e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TGFB1—liver cancer	2.07e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—liver cancer	2.06e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—liver cancer	2.06e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—liver cancer	2.06e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—liver cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—liver cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PIK3CA—liver cancer	2.04e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PIK3CA—liver cancer	2.04e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—liver cancer	2.04e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARG—liver cancer	2.04e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—liver cancer	2.02e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—liver cancer	2.01e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MYC—liver cancer	2.01e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MYC—liver cancer	2.01e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—liver cancer	2.01e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TGFB1—liver cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TGFB1—liver cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—liver cancer	2e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—liver cancer	2e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—liver cancer	1.99e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—liver cancer	1.99e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—liver cancer	1.97e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—liver cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—liver cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—liver cancer	1.95e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	1.93e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—liver cancer	1.93e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—liver cancer	1.93e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KRAS—liver cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—liver cancer	1.91e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IL6—liver cancer	1.91e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—liver cancer	1.89e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IL6—liver cancer	1.88e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IL6—liver cancer	1.88e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IL6—liver cancer	1.87e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—liver cancer	1.87e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IL6—liver cancer	1.87e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KRAS—liver cancer	1.86e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KRAS—liver cancer	1.86e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.85e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IL6—liver cancer	1.85e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IL6—liver cancer	1.84e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ALB—liver cancer	1.83e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PIK3CA—liver cancer	1.83e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—liver cancer	1.79e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—liver cancer	1.76e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3CA—liver cancer	1.76e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—liver cancer	1.74e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—liver cancer	1.73e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—liver cancer	1.73e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—liver cancer	1.73e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—liver cancer	1.72e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—liver cancer	1.72e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL6—liver cancer	1.71e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—liver cancer	1.71e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3CA—liver cancer	1.71e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3CA—liver cancer	1.71e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—liver cancer	1.7e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—liver cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—liver cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—liver cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—liver cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—liver cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—liver cancer	1.63e-06	1.07e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.62e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CA—liver cancer	1.6e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—liver cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—liver cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—liver cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL6—liver cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL6—liver cancer	1.51e-06	9.89e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL6—liver cancer	1.51e-06	9.89e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.51e-06	9.86e-06	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—liver cancer	1.49e-06	9.76e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—liver cancer	1.44e-06	9.43e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—liver cancer	1.39e-06	9.12e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—liver cancer	1.39e-06	9.12e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—liver cancer	1.31e-06	8.55e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.28e-06	8.35e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—liver cancer	1.23e-06	8.05e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—liver cancer	1.04e-06	6.82e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CA—liver cancer	9.85e-07	6.45e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—liver cancer	8.05e-07	5.27e-06	CbGpPWpGaD
